Oscar Health Inc (OSCR) PT Raised to $49 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts OSCR Hot Sheet
Price: $33.61 -0.15%
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 14
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 14
Join SI Premium – FREE
Barclays analyst Andrew Mok raised the price target on Oscar Health Inc (NYSE: OSCR) to $49.00 (from $39.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Oscar Health unveils 2027 insurance plans, enters South Carolina
- Intuitive Surgical (ISRG) PT Lowered to $550 at RBC Capital
- Arcus Biosciences (RCUS) PT Raised to $41 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
